China vs Ireland: The number of people with susceptibility test result for rifampicin
China
79.92
in 2021
Ireland
80
in 2021
China rank
95th
Ireland rank
94th
The number of people with susceptibility test result for rifampicin over time
- China
- Ireland
How they compare
Ireland currently reports 80 against 79.92 in China, a difference of 0.08.
Across all 5 years both countries report, Ireland has been ahead every year.
China ranks 95th and Ireland ranks 94th of 146 countries.
Ireland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.88 | 90.79 | 30.92 | Ireland |
| 2020s | 81.69 | 85.83 | 4.15 | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, China or Ireland?
- Ireland, at 80 against 79.92 in China as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between China and Ireland?
- 0.08, with Ireland ahead.
- How many years of comparable data are there for China and Ireland?
- 5 years are reported by both, from 2017 to 2021.
- How do China and Ireland rank globally for the number of people with susceptibility test result for rifampicin?
- China ranks 95th and Ireland ranks 94th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.